StonvexLoading…
StonvexStonvexStonvexCore line items from RTX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-20 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $23.09B | $22.08B | $88.60B | $64.36B | $41.89B |
Operating Income | Not available | $2.56B | $9.30B | $6.70B | $4.18B |
Net Income | Not available | $2.06B | $6.73B | $5.11B | $3.19B |
EPS (Diluted) | $1.67 | $1.51 | $4.96 | $3.77 | $2.36 |
Total Assets | Not available | $170.43B | $171.08B | $168.67B | $167.14B |
Total Liabilities | Not available | $102.40B | $103.94B | $102.28B | $102.89B |
Cash & Equivalents | Not available | $6.82B | $7.43B | $5.97B | $4.78B |
Free Cash Flow OCF − CapEx | Not available | $1.31B | $7.94B | $4.75B | $720.00M |
Shares Outstanding | Not available | 1.36B | 1.36B | 1.35B | 1.35B |